(Q33643621)

28 July 2017

1 reference

title

Clinician/patient interaction: communicating the benefits and risks of oral contraceptives (English)

1 reference

28 July 2017

Davis A

1

1 reference

28 July 2017

Wysocki S

series ordinal

2

1 reference

28 July 2017

publication date

1 January 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

59

1 reference

28 July 2017

issue

1 Suppl

1 reference

28 July 2017

page(s)

39S-42S

1 reference

Perceptions of contraceptive effectiveness and health effects of oral contraception

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Patient education and understanding: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

The reduction in risk of ovarian cancer associated with oral-contraceptive use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Stroke in users of low-dose oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Oral contraceptive health benefits: perception versus reality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Breast cancer risk: perception versus reality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Cardiovascular risks: perception versus reality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

The noncontraceptive health benefits from oral contraceptive use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900137-1

10.1016/S0010-7824(98)00137-1

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference